Press Release (ePRNews.com) - TORONTO - Jun 11, 2018 - The accelerated arrival of novel vaccines and immunotherapies into the clinical space spurred the emergence of fields like personalized medicine, immune profiling and immuno-monitoring built around increasingly sophisticated testing platforms. Among them, immunoassays in the ELISpot (Enzyme-Linked ImmunoSpot) family are the most frequently used functional assays for single-cell analysis. A relatively recent addition in the clinical testing space is that of multiplexed FluoroSpot assays, which enable simultaneous measurement of different analytes.
Traditional challenges of colorimetric ELISpot assays are, to some extent, magnified during the validation of multiplex FluoroSpot assays and routine sample testing. The new multidimensionality of the data is also a factor to consider.
During a live session on Thursday, June 21, 2018 at 10 a.m. EDT (3 p.m. BST/UK), featured speaker Rolando Pajon, Ph.D., Lead Scientist of Vaccine and Novel Immunotherapeutics at Covance, will present and discuss the innovative take on the field at Covance’s Vaccine and Novel Immunotherapeutic Laboratory.
For more information about this complimentary webinar visit: On the Spot: Multiplex FluoroSpot-Based Testing in Clinical Evaluation of Vaccines and Novel Immunotherapeutics
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar
Contact: Source :
Tel: +1 (416) 977-6555 ext 352